Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors
Authors
Keywords
Trauma, Injuries, Endocannabinoids, Genotype, Depression
Journal
Neurobiology of Stress
Volume 14, Issue -, Pages 100304
Publisher
Elsevier BV
Online
2021-02-06
DOI
10.1016/j.ynstr.2021.100304
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Review of the Relationship Between Emotional Learning and Memory, Sleep, and PTSD
- (2019) Peter J. Colvonen et al. Current Psychiatry Reports
- Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder
- (2019) Jacob D. Meyer et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants
- (2019) Pablo Romero-Sanchiz et al. NEUROPHARMACOLOGY
- Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide)
- (2019) Erin C. Hanlon PSYCHONEUROENDOCRINOLOGY
- The relationship of endocannabinoidome lipid mediators with pain and psychological stress in women with fibromyalgia – a case control study
- (2018) Niclas Stensson et al. JOURNAL OF PAIN
- Weight loss and improved mood after aerobic exercise training are linked to lower plasma anandamide in healthy people
- (2018) Arão Belitardo de Oliveira et al. PHYSIOLOGY & BEHAVIOR
- The Center for Epidemiologic Studies Depression Scale is an adequate screening instrument for depression and anxiety disorder in adults with congential heart disease
- (2017) Ju Ryoung Moon et al. Health and Quality of Life Outcomes
- Risk factors for depression following traumatic injury: An epidemiological study from a scandinavian trauma center
- (2017) Rebecka Ahl et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels
- (2017) ANGELIQUE G. BRELLENTHIN et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
- (2017) Cecilia J Hillard NEUROPSYCHOPHARMACOLOGY
- Abstract # 1781 Relationship between cortisol, endocannabinoids, PTSD and depression immediately and six months after traumatic injury
- (2016) T. deRoon-Cassini et al. BRAIN BEHAVIOR AND IMMUNITY
- Dose-dependent cannabis use, depressive symptoms, andFAAHgenotype predict sleep quality in emerging adults: a pilot study
- (2016) Kristin E. Maple et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Circadian Rhythm of Circulating Levels of the Endocannabinoid 2-Arachidonoylglycerol
- (2015) E. C. Hanlon et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety
- (2015) J. M. Gray et al. JOURNAL OF NEUROSCIENCE
- Exploring Diallelic Genetic Markers: TheHardyWeinbergPackage
- (2015) Jan Graffelman Journal of Statistical Software
- The endocannabinoid system in guarding against fear, anxiety and stress
- (2015) Beat Lutz et al. NATURE REVIEWS NEUROSCIENCE
- Neurobiological Interactions Between Stress and the Endocannabinoid System
- (2015) Maria Morena et al. NEUROPSYCHOPHARMACOLOGY
- Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
- (2014) Cecilia Hillard et al. CURRENT PHARMACEUTICAL DESIGN
- Mechanisms of Exercise-Induced Hypoalgesia
- (2014) Kelli F. Koltyn et al. JOURNAL OF PAIN
- Increased CB2 mRNA and anandamide in human blood after cessation of cannabis abuse
- (2014) Daniela Muhl et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms
- (2013) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans
- (2013) Ulrike Thieme et al. Drug Testing and Analysis
- The Center for Epidemiologic Studies Depression Scale: A Review with a Theoretical and Empirical Examination of Item Content and Factor Structure
- (2013) R. Nicholas Carleton et al. PLoS One
- Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment
- (2013) Marina Mitjans et al. PSYCHOPHARMACOLOGY
- A common functional promoter variant links CNR1 gene expression to HDL cholesterol level
- (2013) Q. Feng et al. Nature Communications
- Increased risk of major depression by childhood abuse is not modified byCNR1genotype
- (2012) John F. Pearson et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Multiple Functions of Endocannabinoid Signaling in the Brain
- (2012) István Katona et al. Annual Review of Neuroscience
- Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and Depression
- (2012) Arpana Agrawal et al. ARCHIVES OF GENERAL PSYCHIATRY
- Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear
- (2012) Kwang Choi et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes
- (2012) Marina Mitjans et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans
- (2012) Andrea Dlugos et al. NEUROPSYCHOPHARMACOLOGY
- The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity
- (2012) E. Heyman et al. Obesity Reviews
- Systematic review of predictive performance of injury severity scoring tools
- (2012) Hideo Tohira et al. Scandinavian Journal of Trauma Resuscitation & Emergency Medicine
- Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1
- (2012) I Heitland et al. Translational Psychiatry
- Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence
- (2011) C.J. Hillard et al. NEUROSCIENCE
- Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats
- (2011) Natale R. Sciolino et al. PHARMACOLOGICAL RESEARCH
- Effect of anaesthesia and cardiopulmonary bypass on blood endocannabinoid concentrations during cardiac surgery
- (2010) F Weis et al. BRITISH JOURNAL OF ANAESTHESIA
- Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers
- (2010) Jamie Horder et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
- (2010) Joel E Schlosburg et al. NATURE NEUROSCIENCE
- Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression
- (2010) Palmiero Monteleone et al. PHARMACOLOGICAL RESEARCH
- A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy
- (2010) Sarah A. Eisenstein et al. PHARMACOLOGICAL RESEARCH
- Endogenous cannabinoid signaling is essential for stress adaptation
- (2010) M. N. Hill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevalence of Posttraumatic Stress Disorder and Major Depression After Trauma Center Hospitalization
- (2010) Regina A. Shih et al. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
- Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with5-HTTLPRaffect the anxious phenotype
- (2009) Judit Lazary et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides
- (2009) K. Yaragudri Vinod et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic–Pituitary–Adrenal Axis
- (2009) Matthew N Hill et al. NEUROPSYCHOPHARMACOLOGY
- Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
- (2009) Matthew N. Hill et al. PSYCHONEUROENDOCRINOLOGY
- Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major Depression
- (2008) Katharina Domschke et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report
- (2008) M. Hill et al. PHARMACOPSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started